Source:http://linkedlifedata.com/resource/pubmed/id/15293602
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2004-8-5
|
pubmed:abstractText |
Mutations in the surfactant protein C gene (SFTPC) were recently reported in patients with interstitial lung disease. In a 13-month-old infant with severe respiratory insufficiency, a lung biopsy elicited combined histological patterns of nonspecific interstitial pneumonia and pulmonary alveolar proteinosis. Immunohistochemical and biochemical analyses showed an intra-alveolar accumulation of surfactant protein (SP)-A, precursors of SP-B, mature SP-B, aberrantly processed proSP-C, as well as mono- and dimeric SP-C. Sequencing of genomic DNA detected a de novo heterozygous missense mutation of the SFTPC gene (g.1286T>C) resulting in a substitution of threonine for isoleucine (173T) in the C-terminal propeptide. At the ultrastructural level, abnormal transport vesicles were detected in type-II pneumocytes. Fusion proteins, consisting of enhanced green fluorescent protein and wild-type or mutant proSP-C, were used to evaluate protein trafficking in vitro. In contrast to wild-type proSP-C, mutant proSP-C was routed to early endosomes when transfected into A549 epithelial cells. In contrast to previously reported mutations, the 173T represents a new class of surfactant protein C gene mutations, which is marked by a distinct trafficking, processing, palmitoylation, and secretion of the mutant and wild-type surfactant protein C. This report heralds the emerging diversity of phenotypes associated with the expression of mutant surfactant C proteins.
|
pubmed:grant | |
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0903-1936
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
24
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
30-9
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:15293602-Base Sequence,
pubmed-meshheading:15293602-Biopsy, Needle,
pubmed-meshheading:15293602-Blotting, Western,
pubmed-meshheading:15293602-Genetic Predisposition to Disease,
pubmed-meshheading:15293602-Genetic Testing,
pubmed-meshheading:15293602-Humans,
pubmed-meshheading:15293602-Immunohistochemistry,
pubmed-meshheading:15293602-Infant, Newborn,
pubmed-meshheading:15293602-Lung Diseases, Interstitial,
pubmed-meshheading:15293602-Male,
pubmed-meshheading:15293602-Molecular Sequence Data,
pubmed-meshheading:15293602-Mutation, Missense,
pubmed-meshheading:15293602-Polymerase Chain Reaction,
pubmed-meshheading:15293602-Prognosis,
pubmed-meshheading:15293602-Protein C,
pubmed-meshheading:15293602-Sensitivity and Specificity
|
pubmed:year |
2004
|
pubmed:articleTitle |
Interstitial lung disease in a baby with a de novo mutation in the SFTPC gene.
|
pubmed:affiliation |
Institute of Pathology, University Hospital Bergmannsheil, Bochum, Germany. Frank.E.Brasch@ruhr-uni-bochum.de
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.,
Review,
Case Reports,
Research Support, Non-U.S. Gov't
|